Targeting Drug Evasion by HIV Reverse Transcriptase - Lawrence Loeb

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Institute of Allergy and Infectious Diseases (NIAID)
Type: Research Project (R01)
Project #: 5R01AI038180-02
Application #: 2075124
Study Section: AIDS and Related Research Study Section 3 (ARRC)

Project Start: 1995-06-01
Project End: 2000-05-31
Budget Start: 1996-06-01
Budget End: 1997-05-31
Support Year: 2
Fiscal Year: 1996
Total Cost
Indirect Cost

Institution

Name: University of Washington
Department: Pathology
Type: Schools of Medicine
DUNS #: 135646524

City: Seattle
State: WA
Country: United States
Zip Code: 98195

Related projects


NIH 1999 R01 AI	Targeting Drug Evasion by HIV Reverse Transcriptase Loeb, Lawrence A. / University of Washington
NIH 1998 R01 AI	Targeting Drug Evasion by HIV Reverse Transcriptase Loeb, Lawrence A. / University of Washington
NIH 1997 R01 AI	Targeting Drug Evasion by HIV Reverse Transcriptase Loeb, Lawrence A. / University of Washington
NIH 1996 R01 AI	Targeting Drug Evasion by HIV Reverse Transcriptase Loeb, Lawrence A. / University of Washington
NIH 1995 R01 AI	Targeting Drug Evasion by HIV Reverse Transcriptase Loeb, Lawrence A. / University of Washington

Publications

Kamath-Loeb, A S; Hizi, A; Kasai, H et al. (1997) Incorporation of the guanosine triphosphate analogs 8-oxo-dGTP and 8-NH2-dGTP by reverse transcriptases and mammalian DNA polymerases. J Biol Chem 272:5892-8

Suzuki, M; Christians, F C; Kim, B et al. (1996) Tolerance of different proteins for amino acid diversity. Mol Divers 2:111-8

Comments

Be the first to comment on Lawrence Loeb's grant